PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Potassium Acetate→

Potassium Acetate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
127-08-2
Molecular formula
C2H3KO2
Molecular weight
98.14 g/mol
Drug class
Potassium saltintravenous electrolyte replacement and alkalinising precursor
Mechanism of action
Dissociates to provide potassium ions, which are essential for resting membrane potential, neuromuscular transmission and cardiac conduction. Acetate is metabolised to bicarbonate and can contribute to alkalinisation.
Indications / reported uses
  • Prevention and treatment of potassium depletion when intravenous replacement is indicated, particularly when chloride administration is undesirable; dose and infusion rate require electrolyte and cardiac monitoring

Sources: US DailyMed — Potassium acetate injection · NLM MeSH — Potassium acetate · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Potassium Acetate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Potassium Acetate Permitted Daily Exposure (PDE) report (the Potassium Acetate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Potassium Acetate Occupational Exposure Limit (OEL) report (the Potassium Acetate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.